These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32455132)

  • 1. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling.
    Zhang K; Zheng S; Wu J; He J; Ouyang Y; Ao C; Lang R; Jiang Y; Yang Y; Xiao H; Li Y; Li M; Wang H; Li C; Wu D
    FASEB J; 2024 Apr; 38(7):e23599. PubMed ID: 38572590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
    He J; Liu B; Du X; Wei Y; Kong D; Feng B; Guo R; Asiamah EA; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
    Stem Cell Res Ther; 2024 Mar; 15(1):66. PubMed ID: 38443965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.
    Lv S; Cheng J; Sun A; Li J; Wang W; Guan G; Liu G; Su M
    Diabetes Res Clin Pract; 2014 Apr; 104(1):143-54. PubMed ID: 24513119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
    Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization.
    Zhang Y; Le X; Zheng S; Zhang K; He J; Liu M; Tu C; Rao W; Du H; Ouyang Y; Li C; Wu D
    Stem Cell Res Ther; 2022 Apr; 13(1):171. PubMed ID: 35477552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model.
    An X; Liao G; Chen Y; Luo A; Liu J; Yuan Y; Li L; Yang L; Wang H; Liu F; Yang G; Yi S; Li Y; Cheng J; Lu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):363. PubMed ID: 31791397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy.
    Liu Q; Lv S; Liu J; Liu S; Wang Y; Liu G
    Diabetes Res Clin Pract; 2020 Apr; 162():108093. PubMed ID: 32109518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy.
    Chen K; Yu B; Liao J
    Mol Med; 2021 Jul; 27(1):71. PubMed ID: 34238205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
    Bai Y; Huang L; Fan Y; Li Y
    FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
    Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
    Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.